Synthorx (Synthorx) Days Inventory : 0.00 (As of Sep. 2019)

View and export this data going back to 2018. Start your Free Trial

What is Synthorx Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Synthorx's Average Total Inventories for the three months ended in Sep. 2019 was $0.00 Mil. Synthorx's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.00 Mil.

The historical rank and industry rank for Synthorx's Days Inventory or its related term are showing as below:

THOR's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 191.14
* Ranked among companies with meaningful Days Inventory only.

Synthorx's Days Inventory stayed the same from Sep. 2018 (0.00) to Sep. 2019 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Synthorx Days Inventory Historical Data

The historical data trend for Synthorx's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx Days Inventory Chart

Synthorx Annual Data

Trend

Dec16

Dec17

Dec18

Days Inventory

Synthorx Quarterly Data
	Dec16	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Days Inventory	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Synthorx's Days Inventory

For the Biotechnology subindustry, Synthorx's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthorx's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthorx's Days Inventory distribution charts can be found below:

* The bar in red indicates where Synthorx's Days Inventory falls into.

Synthorx Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Synthorx's Days Inventory for the fiscal year that ended in Dec. 2018 is calculated as

	Days Inventory (A: Dec. 2018 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2017 )	+	Total Inventories (A: Dec. 2018 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2018 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Synthorx's Days Inventory for the quarter that ended in Sep. 2019 is calculated as:

	Days Inventory (Q: Sep. 2019 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2019 )	+	Total Inventories (Q: Sep. 2019 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2019 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Synthorx (NAS:THOR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Synthorx's Inventory Turnover for the three months ended in Sep. 2019 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Synthorx's Inventory to Revenue for the three months ended in Sep. 2019 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Synthorx Days Inventory Related Terms

Thank you for viewing the detailed overview of Synthorx's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthorx (Synthorx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037

Website

http://www.synthorx.com

Executives

Powell Andrew Kenneth William	director	C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p.	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky	director, 10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson	director, 10 percent owner	C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter	director	C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver	director, officer: President and CEO	1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p.	10 percent owner	1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc	10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022